Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SB225002
i
Other names:
SB225002, SB 225002
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
GSK
Drug class:
CXCR2 antagonist
Related drugs:
‹
SX-682 (2)
AZD5069 (0)
CXCR2 and NGFR transduced TIL (0)
MK-7123 (0)
DF 1681Y (0)
SX-682 (2)
AZD5069 (0)
CXCR2 and NGFR transduced TIL (0)
MK-7123 (0)
DF 1681Y (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CCL20 overexpression
Breast Cancer
CCL20 overexpression
Breast Cancer
SB225002
Sensitive: D – Preclinical
SB225002
Sensitive
:
D
SB225002
Sensitive: D – Preclinical
SB225002
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login